Tirzepatide is a popular weight loss and diabetes medication that is both a GLP-1 and a GIP (glucose-dependent insulinotropic polypeptide)
However, they showed great promise in metabolic functions and appetite regulation, making them a great tool for medically-managed weight loss
Absence of Common Growth Hormone Side Effects: Because AOD-9604 does not bind to growth hormone receptors or elevate IGF-1, it avoids edema and fluid retention, joint pain and stiffness, carpal tunnel syndrome, glucose elevation and insulin resistance, increased cancer risk concerns from IGF-1 elevation, organ growth or acromegaly features with long-term use, and thyroid function suppression
Clin Endocrinol 40:393400 Jrgensen JO, Pedersen SA, Thuesen L, Jrgensen J, Ingemann-Hansen T, Skakkebaek NE, Christiansen JS (1989) Beneficial effects of growth hormone treatment in GH-deficient adults
This compound has not been evaluated by the FDA, and it should not be used to diagnose, treat, cure, or prevent any disease.
The comparison of BPC-157 to other Recovery Peptides is shown in the table below